Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpts.com
ENDPOINTS NEWS
Get the latest updates from ENDPOINTS NEWS directly as they happen.
Follow now 168 followers
Latest posts
Last updated about 6 hours ago
Sarepta says it won't pull Duchenne gene therapy, setting up showdown with FDA
about 6 hours ago
Sarepta Therapeutics said it won't comply with an FDA request to stop...
FDA adcomm votes against Otsuka's Rexulti-Zoloft combo for PTSD
about 10 hours ago
The FDA’s Psychopharmacologic Drugs Advisory Committee on Friday voted 10-1 against the...
Sail Bio cuts staff by 30% and trims leadership team
about 11 hours ago
Sail Biomedicines, a well-funded startup that once aspired to become Moderna 2.0...
Peter Marks says Sarepta gene therapy pause 'makes sense'
about 11 hours ago
Former CBER chief Peter Marks says that a decision to pause shipments...
FDA rejects expanded label for Roche's Columvi
about 12 hours ago
The FDA issued a complete response letter to Roche’s Columvi, saying the...
FDA asks Sarepta to stop selling Duchenne treatment, following patient deaths
about 13 hours ago
The FDA will ask Sarepta to stop shipping its Duchenne muscular dystrophy...
David Baker’s lab uses AI to help catch nature’s squirmiest proteins
about 15 hours ago
In the wide world of traditionally undruggable proteins, one group stands out...
Bristol Myers Squibb’s Reblozyl fails Phase 3 in anemia; Sanofi, Blueprint deal closes
about 15 hours ago
Plus, news about DiaMedica Therapeutics, Cantargia and Quetzal Therapeutics Bristol Myers Squibb...
Viatris’ ophthalmic drug flunks Phase 3 study, company mulls next steps
about 16 hours ago
Viatris said Friday its treatment candidate for a common form of eye...
#IAS25: HIV activists, scientists press for change, fueled by excitement for new PrEP tools
about 16 hours ago
KIGALI, RWANDA — Emotions ran high this week at one of the...
Bill Anderson to stay on at Bayer; C-suite changes at troubled Sarepta
about 19 hours ago
Lots to recap this week for Peer Review → Bayer CEO Bill...
Sarepta patient dies in study for limb-girdle muscular dystrophy, raising more safety concerns
1 day ago
Sarepta Therapeutics said that a patient died in a clinical trial testing...